Nextech Invest Ltd

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Nextech Invest Ltd
CRD #322629
SEC #802-126620
CIK #0001911010, 0001595430
AUM
Employees
Phone410443666611
AddressBahnhofstrasse 18
Zurich, Switzerland
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($)
1.00.80.60.40.20.02010201520212027
Sector Form 13F Holdings Value ($M)
Revolution Medicines Inc 739.2
TYRA Biosciences Inc 155.3
BCTG Acquisition Corp 152.0
Oric Pharmaceuticals Inc 90.8
Alumis Inc 78.0
Relay Therapeutics Inc 55.0
Zymeworks Inc 27.9
Kymera Therapeutics Inc 23.2
CytomX Therapeutics Inc 20.9
Context Therapeutics Inc 19.4
View All
Holdings by Sector ($M)
1500120090060030002020202220242027
Type Form D Funds Date Sold AUM
PE Nextech V Oncology SCS SICAV-SIF [2026-03-27] 46.7 M 295.7 M
Offered $350,000,000 · Filed 2017-09-20 (D) · Exemption 506(b) · Minimum $1,000,000 · Remaining $303,258,500 · Duration More than one year · Net Assets Decline to Disclose
PE Nextech VIII SCSP [2025-03-31] 297.5 M 538.0 M
Filed 2024-10-24 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Nextech Crossover I SCSP [2022-08-25] 208.2 M 457.6 M
Filed 2023-04-13 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
PE Nextech VII Oncology SCSP [2022-08-25] 247.1 M 322.3 M
Filed 2023-04-13 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
AUM Breakdown Accounts AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 0 0.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 0 0.0
Total 0 0.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.0
Total 0 0.0
Form D Directors Role # Filings # Firms 2011 - 2026
Ian Charoub Executive Officer 18 8
Costas Constantinides Executive Officer 15 6
Thilo Schroeder Executive Officer 21 3
Rocco Sgobbo Executive Officer 8 3
Dalia Bleyer Executive Officer 7 3
Jacob Loven Executive Officer 6 3
Alfred Scheidegger Executive Officer 6 3
James Pledger Executive Officer 3 3
Jakob Loven Executive Officer 14 2
Nextech Crossover I GP Sa RL Director 2 2
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001595430]
13F-HR [0001911010]
Firm Profile (Form ADV)
Fund TypesPrivate Equity
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com